Pharmaceutical lifecycle management : making the most of each and every brand / Tony Ellery and Neal Hansen

By: Ellery, Tony [author]Contributor(s): Hansen, Neal [co-author]Material type: TextTextPublication details: Hoboken : John Wiley & Sons, c2012Description: xxii, 389 pages : illustrations ; 24 cmISBN: 9780470487532Subject(s): a | DRUG APPROVAL -- ECONOMIC ASPECTS | ECONOMICS, PHARMACEUTICAL -- LEGISLATION & JURISPRUDENCE | | PHARMACEUTICAL PREPARATIONS -- ECONOMICSLOC classification: HD 9666.5 .E45 2012
Contents:
pt. A. Lifecycle management business environment -- pt. B. Lifecycle management regulatory and legal environment -- pt. C. Patents and exclusivities -- pt. D. Developmental LCM -- pt. E. Commercial LCM -- pt. F. Biologics and biosimilars -- pt. G. The integrated brand LCM strategy and its implementation -- pt. H. Integrating LCM with portfolio management.
Summary: A comprehensive guide to optimizing the lifecycle management of pharmaceutical brandsThe mounting challenges posed by cost containment policies and the prevalence of generic alternatives make optimizing the lifecycle management (LCM) of brand drugs essential for pharmaceutical companies looking to maximize the value of their products. Demonstrating how different measures can be combined to create winning strategies, Pharmaceutical Lifecycle Management: Making the Most of Each and Every Brand explores this increasingly important field to help readers understand what they can--and must--do to get.
Item type: Books
Tags from this library: No tags from this library for this title. Log in to add tags.
    Average rating: 0.0 (0 votes)
Item type Current library Home library Collection Shelving location Call number Copy number Status Date due Barcode
Books Books LRC - Main
National University - Manila
Pharmacy General Circulation GC HD 9666.5 .E45 2012 (Browse shelf (Opens below)) c.1 Available NULIB000012131

Includes bibliographical references and index.

pt. A. Lifecycle management business environment -- pt. B. Lifecycle management regulatory and legal environment -- pt. C. Patents and exclusivities -- pt. D. Developmental LCM -- pt. E. Commercial LCM -- pt. F. Biologics and biosimilars -- pt. G. The integrated brand LCM strategy and its implementation -- pt. H. Integrating LCM with portfolio management.

A comprehensive guide to optimizing the lifecycle management of pharmaceutical brandsThe mounting challenges posed by cost containment policies and the prevalence of generic alternatives make optimizing the lifecycle management (LCM) of brand drugs essential for pharmaceutical companies looking to maximize the value of their products. Demonstrating how different measures can be combined to create winning strategies, Pharmaceutical Lifecycle Management: Making the Most of Each and Every Brand explores this increasingly important field to help readers understand what they can--and must--do to get.

There are no comments on this title.

to post a comment.

© 2021 NU LRC. All rights reserved.Privacy Policy I Powered by: KOHA